Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

145.36 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 764
Open 145.36
Bid (Size) 144.91 (1)
Ask (Size) 145.68 (1)
Prev. Close 145.36
Today's Range 145.36 - 145.36
52wk Range 115.61 - 497.49
Shares Outstanding 400,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
What Are Whales Doing With Moderna
A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 13 strange trades. 
Via Benzinga

Performance

YTD
-38.16%
-38.16%
1 Month
+0.02%
+0.02%
3 Month
-16.02%
-16.02%
6 Month
-41.12%
-41.12%
1 Year
-34.80%
-34.80%

More News

Read More
Walmart And 3 Other Stocks Insiders Are Selling
Via Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
Via InvestorPlace
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes
Via Investor's Business Daily
Moderna To establish New Vaccine Facility In Britain
Via Benzinga
Moderna Has Multi-Billion-Dollar Opportunity Outside Of COVID-19 Vaccines, Analyst Says
Via Benzinga
This Is What Whales Are Betting On Moderna
Via Benzinga
So What's Going On With Moderna Shares Rising Today?
Via Benzinga
Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants
Via Benzinga
Benzinga Before The Bell: Executive Shakeup At Amazon, Boeing Supply Chain Warning, Apple's Tim Cook Says 'Stay Tuned' On AR/MR And Other Top Financial Stories Wednesday, June 22
Via Benzinga
Moderna Announces Bivalent Booster mRNA-1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants BA.4 And BA.5
From Moderna, Inc.
Via AccessWire
Exposures COVID-19
Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom
From Moderna, Inc.
Via AccessWire
Looking Into Moderna's Recent Short Interest
Via Benzinga
Looking At Moderna's Recent Whale Trades
Via Benzinga
Pfizer, Moderna Snag FDA OK For Covid Shots In Children At 6 Months Old
Via Investor's Business Daily
Moderna Receives FDA Authorization for Emergency Use of Its COVID-19 Vaccine for Children 6 Months of Age and Older
From Moderna, Inc.
Via AccessWire
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Via Benzinga
Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16
Via Benzinga
Novavax Stock Can Rally, But It’s Still Facing Many Obstacles
Via InvestorPlace
Moderna Plans COVID-19 Vaccine Trial For Infants: WSJ
Via Benzinga
FDA Committee Backs Pfizer, Moderna COVID-19 Vaccines For Toddlers, Youngest Children
Via Benzinga
Retail Sales Comes In Weaker Than Expected And Even Worse When Accounting For Inflation
Via Benzinga
As Omicron Surges, FDA Mulls Pfizer, Moderna Covid Shots For Babies
Via Investor's Business Daily
$100 Invested In This Stock 10 Years Ago Would Be Worth $3,600 Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.